Variants in MC2R account for about 25% of FGD cases, the majority of which are non-conservative, single amino acid substitutions that likely abrogate cyclic adenosine monophosphate (cAMP) generation and impair receptor trafficking (17–19). Here, MC2R is linked to Aarskog-Scott syndrome, X-linked.